{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:43:15Z","timestamp":1790772195517,"version":"4.1.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL141335"],"award-info":[{"award-number":["HL141335"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL141981"],"award-info":[{"award-number":["HL141981"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011918","name":"Hemophilia of Georgia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000019","name":"National Hemophilia Foundation","doi-asserted-by":"publisher","award":["Judith Graham Pool Postdoctoral Award"],"award-info":[{"award-number":["Judith Graham Pool Postdoctoral Award"]}],"id":[{"id":"10.13039\/100000019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Humoral immunity to factor VIII (FVIII) represents a significant challenge for the treatment of patients with hemophilia A. Current paradigms indicate that neutralizing antibodies against FVIII (inhibitors) occur through a classical CD4 T cell, germinal center (GC) dependent process. However, clinical observations suggest that the nature of the immune response to FVIII may differ between patients. While some patients produce persistent low or high inhibitor titers, others generate a transient response. Moreover, FVIII reactive memory B cells are only detectable in some patients with sustained inhibitor titers. The determinants regulating the type of immune response a patient develops, let alone how the immune response differs in these patients remains incompletely understood. One hypothesis is that polymorphisms within immunoregulatory genes alter the underlying immune response to FVIII, and thereby the inhibitor response. Consistent with this, studies report that inhibitor titers to FVIII differ in animals with the same<jats:italic>F8<\/jats:italic>pathogenic variant but completely distinct backgrounds; though, how these genetic disparities affect the immune response to FVIII remains to be investigated. Given this, we sought to mechanistically dissect how genetics impact the underlying immune response to FVIII. In particular, as the risk of producing inhibitors is weakly associated with differences in HLA, we hypothesized that genetic factors other than HLA influence the immune response to FVIII and downstream inhibitor formation. Our data demonstrate that FVIII deficient mice encoding the same MHC and<jats:italic>F8<\/jats:italic>variant produce disparate inhibitor titers, and that the type of inhibitor response formed associates with the ability to generate GCs. Interestingly, the formation of antibodies through a GC or non-GC pathway does not appear to be due to differences in CD4 T cell immunity, as the CD4 T cell response to an immunodominant epitope in FVIII was similar in these mice. These results indicate that genetics can impact the process by which inhibitors develop and may in part explain the apparent propensity of patients to form distinct inhibitor responses. Moreover, these data highlight an underappreciated immunological pathway of humoral immunity to FVIII and lay the groundwork for identification of biomarkers for the development of approaches to tolerize against FVIII.<\/jats:p>","DOI":"10.3389\/fimmu.2022.880829","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T18:45:08Z","timestamp":1652294708000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway"],"prefix":"10.3389","volume":"13","author":[{"given":"Seema R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taran S.","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallace Hunter","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest T.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Jajosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Zerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra D.","family":"Josephson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Doering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Meeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00626.x","article-title":"Inhibitors: Resolving Diagnostic and Therapeutic Dilemmas","volume":"8","author":"Dimichele","year":"2002","journal-title":"Haemophilia"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516437","article-title":"A Randomized Trial of Factor Viii and Neutralizing Antibodies in Hemophilia A","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-577643","article-title":"Toward Optimal Therapy for Inhibitors in Hemophilia","volume":"124","author":"Kempton","year":"2014","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23957","article-title":"United States Hemophilia Treatment Center N. Impact of Inhibitors on Hemophilia a Mortality in the United States","volume":"90","author":"Walsh","year":"2015","journal-title":"Am J Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2013.06.002","article-title":"Hemophilia a in the Third Millennium","volume":"27","author":"Franchini","year":"2013","journal-title":"Blood Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0941","article-title":"Cost of Care and Quality of Life for Patients With Hemophilia Complicated by Inhibitors: The Cocis Study Group","volume":"102","author":"Gringeri","year":"2003","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830420408","article-title":"Loss of High-Responder Inhibitors in Patients With Severe Hemophilia a and Human Immunodeficiency Virus Type 1 Infection: A Report From the Multi-Center Hemophilia Cohort Study","volume":"42","author":"Bray","year":"1993","journal-title":"Am J Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000650","article-title":"Induction of Activated T Follicular Helper Cells Is Critical for Anti-FvIII Inhibitor Development in Hemophilia a Mice","volume":"3","author":"Jing","year":"2019","journal-title":"Blood Adv"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200009)30:9<2548::AID-IMMU2548>3.0.CO;2-H","article-title":"Role of Cd154 in the Secondary Immune Response: The Reduction of Pre-Existing Splenic Germinal Centers and Anti-Factor VIII Inhibitor Titer","volume":"30","author":"Qian","year":"2000","journal-title":"Eur J Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1616733","article-title":"Blockade of Cd40\/Cd40 Ligand Interactions Prevents Induction of Factor VIII Inhibitors in Hemophilic Mice But Does Not Induce Lasting Immune Tolerance","volume":"86","author":"Reipert","year":"2001","journal-title":"Thromb Haemost"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29589284147.x","article-title":"Disappearance of Inhibitor to Factor Viii in Hiv-Infected Hemophiliacs With Progression to Aids or Severe Arc","volume":"29","author":"Ragni","year":"1989","journal-title":"Transfusion"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002731","article-title":"The Prospective Hemophilia Inhibitor Pup Study Reveals Distinct Antibody Signatures Prior to FVIII Inhibitor Development","volume":"4","author":"Reipert","year":"2020","journal-title":"Blood Adv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-598268","article-title":"Affinity of Fviii-Specific Antibodies Reveals Major Differences Between Neutralizing and Nonneutralizing Antibodies in Humans","volume":"125","author":"Hofbauer","year":"2015","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-444877","article-title":"Distinct Characteristics of Antibody Responses Against Factor VIII in Healthy Individuals and in Different Cohorts of Hemophilia a Patients","volume":"121","author":"Whelan","year":"2013","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2516.2008.01962.x","article-title":"Modulation of Factor VIII-Specific Memory B Cells","volume":"16","author":"Reipert","year":"2010","journal-title":"Haemophilia"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02736.x","article-title":"Factor VIII-Specific Memory B Cells in Patients With Hemophilia a","volume":"5","author":"van Helden","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2516.2010.02215.x","article-title":"Factor Viii-Specific B Cell Responses in Haemophilia a Patients With Inhibitors","volume":"16","author":"van Helden","year":"2010","journal-title":"Haemophilia"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.657","article-title":"Hemophilia and Inhibitors: Current Treatment Options and Potential New Therapeutic Approaches","volume":"2016","author":"Meeks","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1648828","article-title":"Immune Tolerance in Hemophilia-Principal Results From the International Registry. Report of the Factor VIII and Ix Subcommittee","volume":"72","author":"Mariani","year":"1994","journal-title":"Thromb Haemost"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-369132","article-title":"The Principal Results of the International Immune Tolerance Study: A Randomized Dose Comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13143","article-title":"Inhibitor Recurrence After Immune Tolerance Induction: A Multicenter Retrospective Cohort Study","volume":"13","author":"Antun","year":"2015","journal-title":"J Thromb Haemost"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483263","article-title":"Factor VIII Gene (F8) Mutation and Risk of Inhibitor Development in Nonsevere Hemophilia a","volume":"122","author":"Eckhardt","year":"2013","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 Gene Mutation Type and Inhibitor Development in Patients With Severe Hemophilia A: Systematic Review and Meta-Analysis","volume":"119","author":"Gouw","year":"2012","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-434803","article-title":"The Polygenic Nature of Inhibitors in Hemophilia A: Results From the Hemophilia Inhibitor Genetics Study (Higs) Combined Cohort","volume":"121","author":"Astermark","year":"2013","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3918","article-title":"Polymorphisms in the Il10 But Not in the Il1beta and Il4 Genes Are Associated With Inhibitor Development in Patients With Hemophilia A","volume":"107","author":"Astermark","year":"2006","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02290.x","article-title":"Polymorphisms in the Ctla-4 Gene and Inhibitor Development in Patients With Severe Hemophilia A","volume":"5","author":"Astermark","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-024711","article-title":"Polymorphisms in the Tnfa Gene and the Risk of Inhibitor Development in Patients With Hemophilia A","volume":"108","author":"Astermark","year":"2006","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655944","article-title":"Hla Class Ii Profile: A Weak Determinant of Factor VIII Inhibitor Development in Severe Haemophilia A. Ukhcdo Inhibitor Working Party","volume":"77","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655945","article-title":"Hla Genotype of Patients With Severe Haemophilia a Due to Intron 22 Inversion With and Without Inhibitors of Factor Viii","volume":"77","author":"Oldenburg","year":"1997","journal-title":"Thromb Haemost"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03636.x","article-title":"Impact of Polymorphisms of the Major Histocompatibility Complex Class II, Interleukin-10, Tumor Necrosis Factor-Alpha and Cytotoxic T-Lymphocyte Antigen-4 Genes on Inhibitor Development in Severe Hemophilia A","volume":"7","author":"Pavlova","year":"2009","journal-title":"J Thromb Haemost"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02397.x","article-title":"Immunoglobulin Isotypes and Functional Anti-FVIII Antibodies in Response to Fviii Treatment in Balb\/C and C57bl\/6 Haemophilia a Mice","volume":"17","author":"Qadura","year":"2011","journal-title":"Haemophilia"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037671","article-title":"Transient B Cell Depletion or Improved Transgene Expression by Codon Optimization Promote Tolerance to Factor VIII in Gene Therapy","volume":"7","author":"Sack","year":"2012","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/jth.13301","article-title":"Canine Models of Inherited Bleeding Disorders in the Development of Coagulation Assays, Novel Protein Replacement and Gene Therapies","volume":"14","author":"Nichols","year":"2016","journal-title":"J Thromb Haemost"},{"key":"B34","article-title":"The Malmo International Brother Study (Mibs). Genetic Defects and Inhibitor Development in Siblings With Severe Hemophilia A","volume":"90","author":"Astermark","year":"2005","journal-title":"Haemato"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-119","article-title":"Targeted Disruption of the Mouse Factor VIII Gene Produces a Model of Haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13202","article-title":"Characterization of a Genetically Engineered Mouse Model of Hemophilia a With Complete Deletion of the F8 Gene","volume":"14","author":"Chao","year":"2016","journal-title":"J Thromb Haemost"},{"key":"B37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1432-1033.1995.tb20776.x","article-title":"Novel Forms of B-Domain-Deleted Recombinant Factor Viii Molecules. Construction and Biochemical Characterization","volume":"232","author":"Lind","year":"1995","journal-title":"Eur J Biochem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/s0958-1669(97)80036-5","article-title":"Eukaryotic Protein Processing: Endoproteolysis of Precursor Proteins","volume":"8","author":"Seidah","year":"1997","journal-title":"Curr Opin Biotechnol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.1.137.137","article-title":"Molecular Characterization of Commercial Porcine Factor Viii Concentrate","volume":"71","author":"Lollar","year":"1988","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-412361","article-title":"A Major Determinant of the Immunogenicity of Factor VIII in a Murine Model Is Independent of Its Procoagulant Function","volume":"120","author":"Meeks","year":"2012","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1055\/s-0039-1689482","article-title":"Proceedings: A More Uniform Measurement of Factor VIII Inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02135.x","article-title":"Neutralization of Antifactor Viii Inhibitors by Recombinant Porcine Factor Viii","volume":"4","author":"Barrow","year":"2006","journal-title":"J Thromb Haemost"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1653759","article-title":"The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability","volume":"73","author":"Verbruggen","year":"1995","journal-title":"Thromb Haemost"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-254755","article-title":"Rational Design of a Fully Active, Long-Acting Pegylated Factor V for Hemophilia a Treatment","volume":"116","author":"Mei","year":"2010","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009376","article-title":"Marginal Zone B Cells Mediate a Cd4 T-Cell-Dependent Extrafollicular Antibody Response Following Rbc Transfusion in Mice","volume":"138","author":"Zerra","year":"2021","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03571.x","article-title":"Splenic Marginal Zone Antigen-Presenting Cells Are Critical for the Primary Allo-Immune Response to Therapeutic Factor VIII in Hemophilia A","volume":"7","author":"Navarrete","year":"2009","journal-title":"J Thromb Haemost"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-374645","article-title":"Cd4+ T-Cell Epitopes Associated With Antibody Responses After Intravenously and Subcutaneously Applied Human FVIII in Humanized Hemophilic E17 Hla-Drb1*1501 Mice","volume":"119","author":"Steinitz","year":"2012","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-782912","article-title":"Marginal Zone B Cells Are Critical to Factor VIII Inhibitor Formation in Mice With Hemophilia A","volume":"130","author":"Zerra","year":"2017","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614450","article-title":"Inhibitor Antibody Development and T Cell Response to Human Factor Viii in Murine Hemophilia A","volume":"81","author":"Qian","year":"1999","journal-title":"Thromb Haemost"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1612915","article-title":"Mechanism of the Immune Response to Human Factor VIII in Murine Hemophilia A","volume":"85","author":"Wu","year":"2001","journal-title":"Thromb Haemost"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-701805","article-title":"High-Affinity, Noninhibitory Pathogenic C1 Domain Antibodies Are Present in Patients With Hemophilia A and Inhibitors","volume":"128","author":"Batsuli","year":"2016","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.immuni.2018.04.019","article-title":"Naive B Cells With High-Avidity Germline-Encoded Antigen Receptors Produce Persistent Igm(+) and Transient Igg(+) Memory B Cells","volume":"48","author":"Pape","year":"2018","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.immuni.2017.11.023","article-title":"Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested With Germline-Targeting Hiv Vaccine Immunogens","volume":"48","author":"Abbott","year":"2018","journal-title":"Immunity"},{"key":"B54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jim.2009.01.005","article-title":"Engineered Cell Surface Expression of Membrane Immunoglobulin as a Means to Identify Monoclonal Antibody-Secreting Hybridomas","volume":"343","author":"Price","year":"2009","journal-title":"J Immunol Methods"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1126\/science.1201730","article-title":"Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response","volume":"331","author":"Pape","year":"2011","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112272","article-title":"Deletion and Anergy of Polyclonal B Cells Specific for Ubiquitous Membrane-Bound Self-Antigen","volume":"209","author":"Taylor","year":"2012","journal-title":"J Exp Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20111696","article-title":"A Germinal Center-Independent Pathway Generates Unswitched Memory B Cells Early in the Primary Response","volume":"209","author":"Taylor","year":"2012","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402335","article-title":"General Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and Snrnp-Reactive B Cells in Autoimmune Bxd2 Mice","volume":"194","author":"Hamilton","year":"2015","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90289-b","article-title":"Maturation of the Immune Response in Germinal Centers","volume":"67","author":"Berek","year":"1991","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal Center B Cell Dynamics","volume":"45","author":"Mesin","year":"2016","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T Follicular Helper Cell Differentiation, Function, and Roles in Disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176676","article-title":"Bcl6 Mediates the Development of T Follicular Helper Cells","volume":"325","author":"Nurieva","year":"2009","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1126\/science.1175870","article-title":"Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation","volume":"325","author":"Johnston","year":"2009","journal-title":"Science"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.07.002","article-title":"The Transcriptional Repressor Bcl-6 Directs T Follicular Helper Cell Lineage Commitment","volume":"31","author":"Yu","year":"2009","journal-title":"Immunity"},{"key":"B65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0300985811429314","article-title":"Immunological Variation Between Inbred Laboratory Mouse Strains: Points to Consider in Phenotyping Genetically Immunomodified Mice","volume":"49","author":"Sellers","year":"2012","journal-title":"Vet Pathol"},{"key":"B66","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.159.4.1767","article-title":"T Cell Genetic Background Determines Maintenance of Il-12 Signaling: Effects on Balb\/C and B10.D2 T Helper Cell Type 1 Phenotype Development","volume":"159","author":"Guler","year":"1997","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.5.2386","article-title":"Sensitivity Difference to the Suppressive Effect of Prostaglandin E2 Among Mouse Strains: A Possible Mechanism to Polarize Th2 Type Response in Balb\/C Mice","volume":"164","author":"Kuroda","year":"2000","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41598-020-79477-7","article-title":"Elucidating Different Pattern of Immunoregulation in Balb\/C and C57bl\/6 Mice and Their F1 Progeny","volume":"11","author":"Hartmann","year":"2021","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02373.x","article-title":"The Humoral Response to Human Factor Viii in Hemophilia A Mice","volume":"5","author":"Healey","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00427","article-title":"Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus","volume":"9","author":"Malkiel","year":"2018","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B Cell Responses: Cell Interaction Dynamics and Decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The Generation of Antibody-Secreting Plasma Cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055531","article-title":"Memory B Cells of Mice and Humans","volume":"35","author":"Weisel","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1034\/j.1600-065x.2003.00058.x","article-title":"Extrafollicular Antibody Responses","volume":"194","author":"MacLennan","year":"2003","journal-title":"Immunol Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.11.006","article-title":"Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity","volume":"53","author":"Elsner","year":"2020","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.8.4567","article-title":"Altered Migration, Recruitment, and Somatic Hypermutation in the Early Response of Marginal Zone B Cells to T Cell-Dependent Antigen","volume":"174","author":"Phan","year":"2005","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.06.014","article-title":"Somatically Hypermutated Plasmodium-Specific Igm(+) Memory B Cells Are Rapid, Plastic, Early Responders Upon Malaria Rechallenge","volume":"45","author":"Krishnamurty","year":"2016","journal-title":"Immunity"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02469","article-title":"Regulation of the Germinal Center Response","volume":"9","author":"Stebegg","year":"2018","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120774","article-title":"Extrafollicular B Cell Activation by Marginal Zone Dendritic Cells Drives T Cell-Dependent Antibody Responses","volume":"209","author":"Chappell","year":"2012","journal-title":"J Exp Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.11.6879","article-title":"Short-Lived Plasmablasts Dominate the Early Spontaneous Rheumatoid Factor Response: Differentiation Pathways, Hypermutating Cell Types, and Affinity Maturation Outside the Germinal Center","volume":"174","author":"William","year":"2005","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.immuni.2007.12.004","article-title":"Sites and Stages of Autoreactive B Cell Activation and Regulation","volume":"28","author":"Shlomchik","year":"2008","journal-title":"Immunity"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040168","article-title":"Short-Lived Plasmablasts and Long-Lived Plasma Cells Contribute to Chronic Humoral Autoimmunity in Nzb\/W Mice","volume":"199","author":"Hoyer","year":"2004","journal-title":"J Exp Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12741","article-title":"Extrafollicular Responses in Humans and Sle","volume":"288","author":"Jenks","year":"2019","journal-title":"Immunol Rev"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B Cell Responses Correlate With Neutralizing Antibodies and Morbidity in Covid-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.06.013","article-title":"Salmonella Infection Drives Promiscuous B Cell Activation Followed by Extrafollicular Affinity Maturation","volume":"43","author":"Di Niro","year":"2015","journal-title":"Immunity"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060087","article-title":"Antigen Recognition Strength Regulates the Choice Between Extrafollicular Plasma Cell and Germinal Center B Cell Differentiation","volume":"203","author":"Paus","year":"2006","journal-title":"J Exp Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161533","article-title":"Differentiation of Germinal Center B Cells Into Plasma Cells Is Initiated by High-Affinity Antigen and Completed by Tfh Cells","volume":"214","author":"Krautler","year":"2017","journal-title":"J Exp Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011550","article-title":"Antigen Drives Very Low Affinity B Cells to Become Plasmacytes and Enter Germinal Centers","volume":"161","author":"Dal Porto","year":"1998","journal-title":"J Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011550","article-title":"Very Low Affinity B Cells Form Germinal Centers, Become Memory B Cells, and Participate in Secondary Immune Responses When Higher Affinity Competition is Reduced","volume":"195","author":"Dal Porto","year":"2002","journal-title":"J Exp Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/ni803","article-title":"Role of Bcr Affinity in T Cell Dependent Antibody Responses in Vivo","volume":"3","author":"Shih","year":"2002","journal-title":"Nat Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12778","article-title":"Signals That Drive T Follicular Helper Cell Formation","volume":"152","author":"Webb","year":"2017","journal-title":"Immunology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20102065","article-title":"B Cell Priming for Extrafollicular Antibody Responses Requires Bcl-6 Expression by T Cells","volume":"208","author":"Lee","year":"2011","journal-title":"J Exp Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080840","article-title":"Icos-Dependent Extrafollicular Helper T Cells Elicit Igg Production Via Il-21 in Systemic Autoimmunity","volume":"205","author":"Odegard","year":"2008","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.880829\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T23:06:49Z","timestamp":1675552009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.880829\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":93,"alternative-id":["10.3389\/fimmu.2022.880829"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.880829","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"880829"}}